Medical/Pharmaceuticals APAC News & Press Release Distribution

Eurosets Lauded by Frost & Sullivan for its Integrated ECLS System, ECMOLife

Eurosets' ECMOLife device provides safe therapies for ARDS patients by minimizing the risks inherent in mechanical ventilation and for patients with severely compromised heart and lungs functions. LONDON, May 10, 2021 /PRNewswire/ -- Based on its recent analysis of the global extracorporeal memb...

2021-05-10 21:00 1437

Eurosets Lauded by Frost & Sullivan for its Integrated ECLS System, ECMOLife

DOORwaY-90 study for SIR-Spheres® therapy as first-line treatment for hepatocellular carcinoma enrolls first patient

First prospective multicenter U.S.-based trial for indication expansion of SIR-Spheres® Y-90 resin microspheres taking place in 15 sites across the U.S. WOBURN, Mass., May 10, 2021 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced that...

2021-05-10 20:30 1257

Thrombectomy Stroke Treatment Reversing Paralysis and Preventing Death Gets Its Global Day

The first annual "World Stroke Thrombectomy Day" is declared on May 15, 2021 by The Society of Vascular and Interventional Neurology Mission Thrombectomy 2020+ Initiative. MINNEAPOLIS, May 10, 2021 /PRNewswire/ -- The Society of Vascular and Interventional Neurology (SVIN) Mission Thrombectomy 2...

2021-05-10 20:00 1196

INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine

PLYMOUTH MEETING, Pa., May 10, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced positive safety, tolerability ...

2021-05-10 20:00 3449

Viva Biotech and BioMap Reached a Strategic Collaboration Agreement, To Jointly Accelerate the Early Drug Discovery through AI Technology

SHANGHAI, May 10, 2021 /PRNewswire/ -- Hosted by BioMap and Adock, the first generation of China Biocomputing Conference was successfully launched in Suzhou. The conference is aiming to unite with biotech and IT industry partners to create a multi-party integrated industrial ecosystem, and realiz...

2021-05-10 18:21 2555

Invitation to the presentation of Elekta's fiscal year 2020/21

STOCKHOLM, May 10, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the fiscal year 2020/21 at10:00 a.m. CEST on May 28. The year-end report will be published at 7:30 a.m. CET on the same day.The company's development will be presented by Elekta's Presid...

2021-05-10 17:43 2169

CAPA-IVM a promising advance in assisted reproduction for women with PCOS

SINGAPORE, May 10, 2021 /PRNewswire/ -- The first births and on-going well-being of babies born from an advanced assisted reproduction process called CAPA in-vitro oocyte maturation, or IVM, has highlighted the potential of the procedure for millions of women with complex fertility issues includi...

2021-05-10 13:00 1928

Hong Kong government endorses INDICAID(R) in visitation resumption arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 11:30 1719

New focus on male factors critical for success in human fertility treatment

SINGAPORE, May 10, 2021 /PRNewswire/ -- The adverse impact of male factors in assisted reproductive treatments was brought into a clear and disturbing focus at the 10th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE). The ASPIRE Congress, originally to be held in the Philippine...

2021-05-10 10:06 1382

Hong Kong government endorses INDICAID(R) in visitation resumption arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 10:00 1839

Hong Kong Government Endorses INDICAID® in Visitation Resumption Arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 09:36 3181

Improving access and affordability of fertility treatment in low to middle income countries

SINGAPORE, May 8, 2021 /PRNewswire/ -- Mounting concerns about access to infertility treatment in low to middle income countries and measures to address the problem have come into sharp focus at the 10th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE). Countries including Indo...

2021-05-08 15:09 2739

Vakrangee Enters The Online Space With The Launch Of Digital Services

- Through this, company has evolved into the unique O2O (Online to Offline) platform, whereby there is Assistance available through the 10,000+ Physical Kendra store network along with Digital Online Services - Initiated this Unique Hybrid proposition with launch of first Digital service of Tele...

2021-05-07 14:08 3810

WuXi Biologics Completed Three Acquisitions to Enhance its Global Network

SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisitions of a Bayer manufacturing facility in Wuppertal,Germany, the Pfizer China ("Pfizer") manufacturing...

2021-05-07 08:30 4941

The Biofactory To Convert Hospital Facilities Into Isolation Facilities Under Master Agreement Signed

SINGAPORE, May 7, 2021 /PRNewswire/ -- The Biofactory has signed a master supply and servicing agreement with ALPS Pte. Ltd, the public healthcare supply chain agency, to be able to provide portable prefabricated negative pressure anterooms to local public healthcare and research institutions etc...

2021-05-07 08:05 2873

Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA

SEOUL, South Korea, May 7, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), said it has secured a 50% stake in RosVivo Therapeutics Inc., a U.S. new drug developer, as its first investment destination. RosVivo recently developed RSVI-301, a new d...

2021-05-07 07:00 4972

Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA

Communique from annual general meeting in Mentice AB (publ)

STOCKHOLM, May 7, 2021 /PRNewswire/ -- An annual general meeting was held in Mentice AB on6 May 2021. Below follows a summary of the resolutions made at the meeting. Adoption of the income statement and the balance sheet, the consolidated income statement and the consolidated balance sheet and d...

2021-05-07 01:46 1596

COVID-19 has caused 6.9 million deaths globally, more than double what official reports show

SEATTLE, May 6, 2021 /PRNewswire/ -- Globally, COVID-19 has caused approximately 6.9 million deaths, more than double what official numbers show, according toa new analysis by the Institute for Health Metrics and Evaluation (IHME) at theUniversity of Washington School of Medicine. IHME found that...

2021-05-06 23:00 3154

Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility

* Novavax to deliver 350 million doses beginning Q3 2021 * 1.1 billion doses of Novavax vaccine to be available to countries participating in COVAX * Serum Institute of India to provide balance of doses for LMICs * Underscores commitment to global equitable access to Novavax vaccine GAITHE...

2021-05-06 21:53 4702

Asieris and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of APL-1202 and Tislelizumab

SHANGHAI, May 6, 2021 /PRNewswire/ -- Asieris Pharmaceuticals ("Asieris") and BeiGene, Ltd. ("BeiGene") today announced that they have entered into a clinical collaboration agreement to evaluate the safety and efficacy of oral APL-1202 in combination with tislelizumab as neoadjuvant therapy in pa...

2021-05-06 20:33 2128